56 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35159907 | Biomimetic Citrate-Coated Luminescent Apatite Nanoplatforms for Diclofenac Delivery in Inflammatory Environments. | 2022 Feb 6 | 3 |
2 | 35585779 | Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials. | 2022 May 18 | 1 |
3 | 33813964 | Non-ulcerogenic pyrazolyl 2-hydroxychalcones and pyrazolylpyrazolines derived from naturally existing furochromone (khellin): semi-synthesis, docking study and anti-inflammatory activity. | 2021 Apr 5 | 1 |
4 | 33964802 | New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies. | 2021 Jul | 2 |
5 | 34182020 | Recategorization of Non-Aspirin Nonsteroidal Anti-inflammatory Drugs According to Clinical Relevance: Abandoning the Traditional NSAID Terminology. | 2021 Nov | 1 |
6 | 34568119 | Safe and appropriate use of diclofenac in chronic kidney disease: An Indian perspective. | 2021 Jul | 1 |
7 | 31878864 | Pro- and Anti-Inflammatory Cytokine Expression Levels in Macrophages; An Approach to Develop Indazolpyridin-Methanones as a Novel Inflammation Medication. | 2020 | 1 |
8 | 31916080 | Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update. | 2020 Apr | 1 |
9 | 31985369 | Inhibition of Cyclooxygenase Enzyme by Bioflavonoids in Horsegram Seeds Alleviates Pain and Inflammation. | 2020 | 1 |
10 | 28179185 | The use of diclofenac sodium in urological practice: A structural and neurochemical based review. | 2018 Jan | 4 |
11 | 28870762 | Peripheral nerve and diclofenac sodium: Molecular and clinical approaches. | 2018 Jan | 2 |
12 | 29235601 | Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. | 2018 Jan 2 | 2 |
13 | 29238904 | Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies. | 2018 Aug | 1 |
14 | 30083389 | Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations. | 2018 | 1 |
15 | 26823679 | Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. | 2016 | 1 |
16 | 27014880 | Spinal antinflammatory action of Diclofenac. | 2016 Jun | 1 |
17 | 27548780 | Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac. | 2016 | 1 |
18 | 27687548 | NSAIDs diclofenac, indomethacin, and meloxicam highly upregulate expression of ICAM-1 and COX-2 induced by X-irradiation in human endothelial cells. | 2016 Oct 28 | 3 |
19 | 27831630 | Safety and efficacy of low doses of diclofenac on acute pain in the emergency setting. | 2016 Oct | 2 |
20 | 24796327 | Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. | 2014 | 1 |
21 | 25378670 | Preadmission use of nonaspirin nonsteroidal anti-inflammatory drugs and 30-day stroke mortality. | 2014 Nov 25 | 2 |
22 | 23289871 | Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model. | 2013 Jan 5 | 7 |
23 | 20817448 | Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry. | 2011 Jan 5 | 1 |
24 | 21830840 | Randomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety. | 2011 Sep 1 | 1 |
25 | 22091869 | Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR. | 2011 Dec 22 | 3 |
26 | 19841157 | Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. | 2010 Jan | 2 |
27 | 20092437 | A Review on the risk of myocardial infarction associated with the NSAID diclofenac. | 2010 Mar | 3 |
28 | 20237495 | Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP. | 2010 Aug | 1 |
29 | 20470236 | Diclofenac: an update on its mechanism of action and safety profile. | 2010 Jul | 1 |
30 | 20631416 | Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. | 2010 May-Jun | 1 |
31 | 20648923 | In vitro anti-proliferative effects of the willow bark extract STW 33-I. | 2010 | 1 |
32 | 21056807 | Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. | 2010 Nov | 1 |
33 | 19602986 | Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy. | 2009 Aug | 1 |
34 | 20096163 | Field treatment of actinic keratoses - focus on COX-2-inhibitors. | 2009 Dec | 1 |
35 | 18434566 | Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. | 2008 Jun | 1 |
36 | 18674517 | Characterization of eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo. | 2008 Sep 15 | 1 |
37 | 17164136 | Pharmacodynamic of cyclooxygenase inhibitors in humans. | 2007 Jan | 3 |
38 | 17965743 | Antagonism of thromboxane receptors by diclofenac and lumiracoxib. | 2007 Dec | 1 |
39 | 18605234 | Comparison of antinociceptive efficacy and gastroprotection between celecoxib and diclofenac plus misoprostol in rats. | 2007 | 1 |
40 | 16934053 | The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in Scotland. | 2006 Sep | 1 |
41 | 15133778 | Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. | 2004 May | 1 |
42 | 15555544 | Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1). | 2004 Dec 24 | 1 |
43 | 12534640 | Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. | 2003 Jan | 1 |
44 | 12852704 | Valdecoxib: a review. | 2003 Mar | 1 |
45 | 12966366 | Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. | 2003 Sep | 3 |
46 | 14655004 | [Clinical pharmacology of the selective COX-2 inhibitors]. | 2003 Dec | 1 |
47 | 11874389 | Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. | 2002 Mar | 3 |
48 | 11556519 | In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. | 2001 Aug | 1 |
49 | 11742186 | Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. | 2001 Dec | 1 |
50 | 11028250 | Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. | 2000 Oct | 1 |